Single agent paclitaxel as a first-line therapy in advanced urothelial carcinoma: Its efficacy and safety in patients even with pretreatment renal insufficiency

Muh Hwa Yang, Chueh Chuan Yen, Yen Hwa Chang, Ruey Kuen Hsieh, Jin Hwang Liu, Tzeon Jye Chiou, Frank S. Fan, Alex Ton Ling Lin, William Ji Shien Huang, Wei Shu Wang, Kuang Kuo Chen, Po Min Chen*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Single agent paclitaxel as a first-line therapy in advanced urothelial carcinoma: Its efficacy and safety in patients even with pretreatment renal insufficiency'. Together they form a unique fingerprint.

Medicine & Life Sciences